♫musicjinni

Come to the DIA Annual Meeting in San Diego, June 21-25, 2009

video thumbnail
The DIA Annual Meeting is the biopharmaceutical industry's largest, longest running, best-value, global, multidisciplinary event. This year's program offers learning opportunities for EVERYONE and features the biggest names from industry, regulatory, and academia.

Today's changing economic and pharmaceutical climate demands your attendance at this year's Annual Meeting in San Diego.

No matter your area of expertise, job function, or interest, our program has been designed specifically with you in mind. Our program offers a variety of options.

Network with more than 8,700 colleagues
Showcase your products and services along with more than 550 exhibiting companies in attendance
Choose from more than 350 hot topic sessions and 34 tutorials across 26 content areas and 3 mega-tracks
Hear from over 1100 speakers, including representatives from FDA, EMEA, and other global regulatory agencies
Gain continuing education credits
Attend the Networking Reception aboard the USS Midway Museum
FREE Access to ALL Annual Meeting Content with full paid registration
IT'S A GLOBAL EVENT

The Annual Meeting welcomes attendees from all geographic locations, professional categories, and levels of responsibility making it the perfect venue for blending multidisciplinary learning with global networking opportunities.

Register today!
http://www.diahome.org

The Drug Discovery Process

Developments in clinical trials regulation

DEVELOPING CLINICAL TRIAL PROTOCOLS | CLINICAL TRIALS | REGULATORY AFFAIRS

505(b)(2) Planning: Regulatory and Study Conduct Best Practices

DIA 2016 Editor’s Take – SynteractHCR

Drug Development in a Post COVID World

Foundations of Clinical Research

What is TMF Reference model||DIA||Trial master file||Clinical Research

2009 DIA Euromeeting

Medpace

Drug Development with Reimbursement in Mind

South Korea: Navigating the Clinical Trial and Regulatory Environment

IPhO and the MCPHS Fellows Present: Regulatory Affairs and Pharmacovigilance

Panel: European Clinical Trials in a Global Context

The ever-expanding importance of diversity in clinical trials and drug development

New Drug Development and Life Cycle Management

Drug Development and Regulation in the Age of Precision Medicine

Premarketing Clinical Trial Safety

DIA 2019: Utilizing High-Quality Data for Best Patient Access

Theme 1 Access to Innovative Treatments - Susanna Del Signore

Cros Are The New Pharmas in Clinical Trials

COVID-19 Product Development & Clinical Trials: Considerations from European Regulatory Perspectives

Global Regulatory Affairs 2018

What Factors Are Driving The Growth of Clinical Trials In the APAC Region?

How QUMAS manages Clinical and Regulatory Affairs

Dr. Bobby George Presentation at Pharma -2012

What is the The European Medicines Agency?

Theme 1 Access to Innovative Treatments - Dorthe Poulsen

Clinical development for non-developers, part 1 (traditional development)

09 Regulatory, Drug Safety

Disclaimer DMCA